EUVIMEDEUVIMED entdecken
Multizentrische Studie

Risk of bleeding after esophagogastroduodenoscopy with mucosal resection in patients with cirrhosis

Razan Aburumman iD, Saqr Alsakarneh, Sumit Singla

Surgical Endoscopy · 2026

DOI: 10.1007/s00464-025-12446-1 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Surgical Endoscopy, 2026. Verfasst von Razan Aburumman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA. Razanaburumman@outlook.com. Hauptthemen laut MEDLINE: Liver Cirrhosis, Endoscopy, Digestive System, Postoperative Hemorrhage, Endoscopic Mucosal Resection. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Esophagogastroduodenoscopy (EGD) with endoscopic mucosal resection (EMR) is commonly used for evaluating and managing gastrointestinal lesions. This study aimed to assess the 30-day risk of bleeding and other adverse outcomes following EGD-EMR in cirrhotic patients. METHODS: This retrospective cohort study utilized data from the US Collaborative Network to evaluate bleeding risk following EGD-EMR in cirrhotic patients. One-to-one propensity score matching was performed, with the primary outcome being bleeding within 30 days post-procedure. RESULTS: Each cohort included 1,045 patients. Cirrhotic patients had higher risk of post-EGD-EMR bleeding (OR 1.65, 95% CI 1.21-2.25, P = 0.002) and were more likely to require a blood transfusion (OR 2.54, 95% CI 1.21-5.31, P = 0.011). However, ICU admissions (OR 1.33, P = 0.29) and endoscopic reinterventions (OR 1.31, P = 0.25) did not differ significantly. Patients with decompensated cirrhosis had a higher bleeding risk compared to controls (OR 1.62, 95% CI 1.05-2.51, P = 0.03), while those with compensated cirrhosis showed no increased risk (OR 1.16, P = 0.55). DISCUSSION: This study found increased post-procedural bleeding in cirrhotic patients, particularly those with decompensated cirrhosis. Careful pre-procedural management of coagulopathy is crucial to minimize complications in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisEndoscopy, Digestive SystemPostoperative HemorrhageEndoscopic Mucosal ResectionGastrointestinal HemorrhageHumansMaleFemaleRetrospective StudiesMiddle AgedAgedPropensity ScoreRisk FactorsRisk AssessmentBlood Transfusion

Stichwörter der Autor:innen

BleedingCirrhosisEGDEMR

Autor:innen und Institutionen

  • Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA. Razanaburumman@outlook.com.
  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. Razanaburumman@outlook.com.
  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Division of Gastroenterology and Hepatology, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI, 48202, USA.

ORCID-Profile: Razan Aburumman

Zitieren

APA

Aburumman, R., Alsakarneh, S., & Singla, S. (2026). Risk of bleeding after esophagogastroduodenoscopy with mucosal resection in patients with cirrhosis. Surgical Endoscopy. https://doi.org/10.1007/s00464-025-12446-1

Vancouver

Aburumman R, Alsakarneh S, Singla S. Risk of bleeding after esophagogastroduodenoscopy with mucosal resection in patients with cirrhosis. Surgical Endoscopy. 2026. doi:10.1007/s00464-025-12446-1

BibTeX
@article{Aburumman2026,
  author = {Aburumman, Razan and Alsakarneh, Saqr and Singla, Sumit},
  title = {Risk of bleeding after esophagogastroduodenoscopy with mucosal resection in patients with cirrhosis},
  journal = {Surgical Endoscopy},
  year = {2026},
  doi = {10.1007/s00464-025-12446-1}
}
Kostenlos starten →